References
- Bartoletti-Stella A, Baiardi S, Stanzani-Maserati M, Piras S, Caffarra P, Raggi A, et al. Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing. Neurobiol Aging. 2018;66:180.e23–31.
- Fischer CE, Agüera-Ortiz L. Psychosis and dementia: risk factor, prodrome, or cause? Int Psychogeriatr. 2018;30:209–19.
- Sellami L, Bocchetta M, Masellis M, Cash DM, Dick KM, van Swieten J, et al. Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI cohort. JAD. 2018;65:1–163.
- Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, et al. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry. 2013;74:384–91.
- Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011;477:211–15.
- Renaud L, Picher-Martel V, Codron P, Julien JP. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun. 2019;7:103.
- Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Klivényi P, et al. Comprehensive genetic analysis of a hungarian amyotrophic lateral sclerosis cohort. Front Genet. 2019;10:732.
- Lattante S, Le Ber I, Camuzat A, Pariente J, Brice A, Kabashi E. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients. Neurobiol Aging. 2013;34:2078.e5–6.
- Kotan D, Iskender C, Ozoguz Erimis A, Basak AN. A Turkish family with a familial ALS-positive UBQLN2-S340I mutation. Arch Neuropsychiatr. 2016;53:283–5.
- Ugwu F, Rollinson S, Harris J, Gerhard A, Richardson A, Jones M, et al. UBQLN2 variant of unknown significance in frontotemporal lobar degeneration. Neurobiol Aging. 2015;36:546.e15–6.